A Study of PF-07260437 in Advanced or Metastatic Solid Tumors

PHASE1

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped Pfizer has made an internal business decision to not continue further development of PF-07260437. This decision was not due to major safety concerns or requests from any regulatory authorities.

Conditions

Ovarian Neoplasms
Endometrial Neoplasms
Breast Neoplasms

Interventions

DRUG: PF-07260437
DIAGNOSTIC_TEST: B7-H4 IHC

Sponsor

Pfizer